SIFMA 2011: The Role of the CRO Needs to Evolve

At the Sifma conference in New York yesterday, I caught up with FinAnalytica CEO David Merrill. I asked him what he thought had gone under-reported, and he told me about the changing role and description of chief risk officers (CROs) on Wall Street. Here's what he had to say:
"We’ll start to see the profile—the persona—of the chief risk officer change. The type of person who was originally sought out for that role needs to change. If you go back five years, the CRO was a person who came from an accounting background or had strong math skills, or experience in operations. But those people might not have been innovators, or may have been less aggressive in meetings with other businesspeople. Back then, and even today, the CRO may not have been part of the executive team."
“The CRO is an important, vital part of the firm and that needs to be reflected in many different ways. People talk about this, but I think it stops too short: If you want to have effective and influential risk management practices in a firm, they must be embraced by the head of trading, the chief investment officer, the CEO, and the head of sales—the key players in the firm. The CRO has to be persuasive enough to get those people all interested in the objective. If they're not interested individually, then their teams won't be either, and it remains a silo. A silo won't have the necessary impact, won’t get the budget and won’t have the synergistic effects that it could have."
"I think this role will change, and an example is what happened with the role of the CTO. A lot of CTOs weren't great businesspeople, weren't great communicators—they were techie and nerdy. But that's changed. A lot of CTOs are very business-oriented, persuasive and articulate, and they have a lot of impact in terms of strategy. Those are the people who can champion projects that can really transform companies. So I think we need to see the CRO role change in the way that the CTO role has changed."
So I want to hear from you: How has the CRO role changed? How should it change in the future? How important it is to have a technological understanding of the risk management systems, and do most firms have a good risk manager already in place?
Shoot me an email at anthony.malakian@incisivemedia.com or find me at Sifma—I always love to hear from readers.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Emerging Technologies
Waters Wavelength Ep. 331: Cresting Wave’s Bill Murphy
Bill Murphy, Blackstone’s former CTO, joins to discuss that much-discussed MIT study on AI projects failing and factors executives should consider as the technology continues to evolves.
FactSet adds MarketAxess CP+ data, LSEG files dismissal, BNY’s new AI lab, and more
The Waters Cooler: Synthetic data for LLM training, Dora confusion, GenAI’s ‘blind spots,’ and our 9/11 remembrance in this week’s news roundup.
Chief investment officers persist with GenAI tools despite ‘blind spots’
Trading heads from JP Morgan, UBS, and M&G Investments explained why their firms were bullish on GenAI, even as “replicability and reproducibility” challenges persist.
Wall Street hesitates on synthetic data as AI push gathers steam
Deutsche Bank and JP Morgan have differing opinions on the use of synthetic data to train LLMs.
A Q&A with H2O’s tech chief on reducing GenAI noise
Timothée Consigny says the key to GenAI experimentation rests in leveraging the expertise of portfolio managers “to curate smaller and more relevant datasets.”
Etrading wins UK bond tape, R3 debuts new lab, TNS buys Radianz, and more
The Waters Cooler: The Swiss release an LLM, overnight trading strays further from reach, and the private markets frenzy continues in this week’s news roundup.
AI fails for many reasons but succeeds for few
Firms hoping to achieve ROI on their AI efforts must focus on data, partnerships, and scale—but a fundamental roadblock remains.
Waters Wavelength Ep. 330: AI hot takes
It’s Shen and Reb this week talking about AI and the landscape for fintech partnerships.